ELENA
GONZÁLEZ REY
Universidad de Sevilla
Sevilla, EspañaPublicacións en colaboración con investigadores/as de Universidad de Sevilla (22)
2024
-
Cortistatin as a Novel Multimodal Therapy for the Treatment of Parkinson’s Disease
International Journal of Molecular Sciences, Vol. 25, Núm. 2
2013
-
Paradoxical effect of cortistatin treatment and its deficiency on experimental autoimmune encephalomyelitis
Journal of Immunology, Vol. 191, Núm. 5, pp. 2144-2154
-
Preconditioning of microglia by α-synuclein strongly affects the response induced by toll-like receptor (TLR) stimulation
PLoS ONE, Vol. 8, Núm. 11
2010
-
Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis
Annals of the Rheumatic Diseases, Vol. 69, Núm. 1, pp. 241-248
-
Vasoactive intestinal peptide induces cell cycle arrest and regulatory functions in human T cells at multiple levels
Molecular and Cellular Biology, Vol. 30, Núm. 10, pp. 2537-2551
2009
-
Chemical synthesis and characterization of silver-protected vasoactive intestinal peptide nanoparticles
Nanomedicine, Vol. 4, Núm. 8, pp. 919-930
-
Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis
Gut, Vol. 58, Núm. 7, pp. 929-939
-
Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide
Journal of Immunology, Vol. 183, Núm. 7, pp. 4346-4359
-
Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells
Arthritis and Rheumatism, Vol. 60, Núm. 4, pp. 1006-1019
2008
-
Emergence of cortistatin as a new immunomodulatory factor with therapeutic potential in immune disorders
Molecular and Cellular Endocrinology, Vol. 286, Núm. 1-2, pp. 135-140
-
Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: Altered expression and signal in immune cells
Arthritis and Rheumatism, Vol. 58, Núm. 4, pp. 1010-1019
-
In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis
Arthritis and Rheumatism, Vol. 58, Núm. 4, pp. 1026-1037
-
Vasoactive intestinal peptide protects against β-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels
GLIA, Vol. 56, Núm. 10, pp. 1091-1103
2007
-
Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders?
Trends in Pharmacological Sciences, Vol. 28, Núm. 9, pp. 482-491
-
Emerging roles of vasoactive intestinal peptide: A new approach for autoimmune therapy
Annals of the Rheumatic Diseases
-
Regulation of immune tolerance by anti-inflammatory neuropeptides
Nature Reviews Immunology, Vol. 7, Núm. 1, pp. 52-63
-
Tuning immune tolerance with vasoactive intestinal peptide: A new therapeutic approach for immune disorders
Peptides, Vol. 28, Núm. 9, pp. 1833-1846
-
Tuning inflammation with anti-inflammatory neuropeptides
Expert Opinion on Biological Therapy, Vol. 7, Núm. 4, pp. 461-478
-
Vasoactive intestinal peptide and regulatory T-cell induction: a new mechanism and therapeutic potential for immune homeostasis
Trends in Molecular Medicine, Vol. 13, Núm. 6, pp. 241-251
2006
-
Protective role for plasmid DNA-mediated VIP gene transfer in non-obese diabetic mice
Annals of the New York Academy of Sciences